サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：遺伝子パネル市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年
市場調査レポート
商品コード
1303129

遺伝子パネル市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年

Gene Panel Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Component, By Technique, By Design, By Application, By End User, By Region and Competition
出版日: | 発行: TechSci Research | ページ情報: 英文 117 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

遺伝子パネル市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年
出版日: 2023年07月01日
発行: TechSci Research
ページ情報: 英文 117 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の遺伝子パネル市場は、予測期間中に目覚ましい成長を遂げると予測されています。

これは、ダウン症候群、鎌状赤血球症、ステイ・サックス病などの遺伝性疾患の有病率が増加しているためと考えられます。国民の医療意識の高まりと早期診断に対する需要の高まりにより、多くのカップルが出産計画前や妊娠中の遺伝子検査を選択し、予測期間中の市場をさらに押し上げています。低コストで迅速かつ正確な検査が可能であることから、遺伝子パネルの応用が増加しており、市場の成長を促進すると予想されます。さらに、ヘルスケアインフラの改善と遺伝子パネルに関連する研究開発への投資の増加は、今後数年間の市場成長にとって有利な機会を生み出すと期待されています。

慢性疾患の発生率の増加

がん、先天性疾患、心臓発作、関節炎などの慢性疾患の罹患率の増加は、予測期間中に遺伝子パネル市場で成長すると予想されます。遺伝子変異による疾患の増加は、遺伝子パネル検査を必要とします。遺伝子パネル検査は、がんに関連する多くの遺伝子の変化を同時に分析する診断技術です。がん治療の開発・上市に向けた主要企業による遺伝子パネルへの高い需要が、予測期間中の遺伝子パネル市場の成長につながると期待されます。Global cancer observatoryによると、世界中で約19,292,789件の新規がん症例が報告されています。このうち、女性では9,227,484件、男性では約10,065,305件の新規がん症例が報告されています。がんの有病率の増加は、遺伝子パネルの需要を増加させるであろう。高額な費用がかかるため、遺伝子検査は通常、遺伝性疾患のために特定の種類のがんを発症するリスクが高い患者に対してのみ実施されます。これには、喫煙、不健康な生活習慣、運動不足、飲酒などの生活習慣が含まれます。世界保健機関（WHO）によると、先天異常が原因で生後28日以内に死亡する新生児は、世界で毎年29万5,000人に上る。

技術の進歩

臨床診断における個別化された医薬品とともに、高度な医療検査に対する需要の増加は、予測期間において市場成長のための有利な機会を創出するであろう。現在、遺伝子疾患は老年人口に多く、遺伝子パネル市場の成長を幅広く支えています。多くの世界企業が新しく先進的な遺伝子パネルの開発に注力しており、これが今後数年間の市場成長をさらに促進すると予想されます。多くの民間企業や政府機関による新技術開発のための取り組みや投資の増加は、市場成長を後押しする主な要因です。先天性欠損症は、米国では毎年33人に1人の割合で生まれており、これは約12万人の乳児に相当します。

利用可能なカスタマイズ

TechSci Researchでは、所定の市場データを使用して、企業固有のニーズに応じたカスタマイズを提供しています。レポートでは以下のカスタマイズが可能です：

企業情報

  • 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 遺伝子パネルの世界市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • コンポーネント別
    • 技術別
    • デザイン別
    • エンドユーザー別
    • 地域別
    • 企業別
  • 市場マップ
    • コンポーネント別
    • 技術別
    • デザイン別
    • 用途別
    • エンドユーザー別
    • 地域別

第6章 北米の遺伝子パネル市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • コンポーネント別
    • 技術別
    • デザイン別
    • 用途別
    • エンドユーザー別
    • 国別
  • 北米国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の遺伝子パネル市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • コンポーネント別
    • 技術別
    • デザイン別
    • 用途別
    • エンドユーザー別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域の遺伝子パネル市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • コンポーネント別
    • 技術別
    • デザイン別
    • 用途別
    • エンドユーザー別
    • 国別
  • アジア太平洋地域国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米の遺伝子パネル市場展望

  • 市場規模・予測
    • 金額ベース
  • 市場シェアと予測
    • コンポーネント別
    • 技術別
    • デザイン別
    • 用途別
    • エンドユーザー別
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの遺伝子パネル市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • コンポーネント別
    • 技術別
    • デザイン別
    • 用途別
    • エンドユーザー別
    • 国別
  • MEA：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 合併・買収
  • 製品発表

第13章 競合情勢

  • Business Overview
  • Product Offerings
  • Recent Developments
  • Financials（As Reported）
  • Key Personnel
  • SWOT Analysis
    • Illumina, Inc.
    • Agilent Technologies, Inc.
    • Thermo Fischer Scientific, Inc.
    • QIAGEN NV
    • Eurofins Scientific SE
    • Foundation Medicine Inc.
    • Guardant Health, Inc.
    • Myriad Genetic Laboratories Inc.
    • Bio-Rad Laboratories, Inc.
    • F. Hoffmann-La Roche AG

第14章 戦略的提言

目次
Product Code: 14590

Global gene panel market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing prevalence of genetic disorders like Down syndrome, sickle cell disease, stay-Sachs disease, and others. Due to increasing healthcare awareness among the population and rising demand for early diagnosis, lots of couples opt for genetic testing before baby planning or during pregnancy, further boosting the market over the forecast period. Increasing application of gene panels owing to the low cost of the technique and fast and accurate testing is expected to propel market growth. Besides, improving healthcare infrastructure coupled with growing investments in research & development related to gene panels is further expected to create lucrative opportunities for market growth in the coming years.

Growing Incidence of Chronic Diseases

The rising incidence of chronic diseases such as cancer, congenital diseases, heart attack, and arthritis is expected to grow in the gene panel market during the forecast period. Increasing disorders because of genetic mutation demand gene panel testing. It is a diagnostic technique that analyses many genes for cancer-associated alterations at the same time. High demand for gene panels by the major key players to develop and launch cancer therapy is expected to growth of the gene panel market over the forecast period. According to the global cancer observatory, around 19,292,789 new cancer cases were reported worldwide. Out of these, 9,227,484 new cancer cases were reported in females, while the number of new cancer cases reported in men was around 10,065,305. The growing prevalence of cancer will increase the demand for gene panels. Given the high cost, genetic testing is usually only carried out on patients who are at a high risk of developing specific types of cancer because of their heredity disorder. This may include lifestyle factors such as smoking, leading an unhealthy lifestyle, reduced physical activity, and alcohol consumption. According to World Health Organization (WHO), around 295 000 newborns die within 28 days of birth every year worldwide due to congenital anomalies.

Technological Advancements

Increasing demand for advanced medical testing, along with personalized medicines in clinical diagnosis, will create lucrative opportunities for market growth in the forecast period. Currently, genetic disorders are common in the geriatric population, which supports the gene panel market growth extensively. Many global companies are focusing on developing new and advanced gene panels, which is further expected to propel market growth over the coming years. Increasing initiative and investment by many private and government organizations for developing new technology is a major factor that boosts market growth. Birth defects affect 1 in every 33 babies born in the United States each year, which translates into about 120,000 babies.

Market Segmentation

The global gene panel market can be segmented by component, technique, design, application, end-user, and by region. Based on components, the market can be divided into Test Kits and Testing Services. Based on technique, the market can be divided into Amplicon Based Approach and Hybridization Based Approach. Based on the design, the market can be divided into Predesigned Gene Panels and Customized Gene Panels. Based on Application, the market can be segmented into Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics, and Others. Based on end-user, the market can be differentiated into Academic & Research Institutes, Hospital & Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the Global Gene Panel Market on account of the growing demand for gene panel techniques for rising cases of cancer across the globe. A little over 1.9 million new cancer cases are expected to be diagnosed in the United States in 2022, according to the 2022 Cancer Facts & Figures report from the American Cancer Society (ACS).

Market Players

Illumina, Inc., Agilent Technologies, Inc., Thermo Fischer Scientific, Inc., QIAGEN NV, Eurofins Scientific SE, Foundation Medicine Inc., Guardant Health, Inc., Myriad Genetic Laboratories Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG are some of the leading players operating in the Global Gene Panel Market.

Report Scope

In this report, global gene panel market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Gene Panel Market, By Component:

  • Test Kits
  • Testing Services

Gene Panel Market, By Technique:

  • Amplicon Based Approach
  • Hybridization Based Approach

Gene Panel Market, By Design:

  • Predesigned Gene Panel
  • Customized Gene Panel

Gene Panel Market, By Application:

  • Cancer Risk Assessment
  • Diagnosis of Congenital Diseases
  • Pharmacogenetics
  • Others

Gene Panel Market, By End User:

  • Academic & Research Institutes
  • Hospital & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies

Gene Panel Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Gene Panel Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Gene Panel Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Component (Test Kits v/s Testing Services)
    • 5.2.2. By Technique (Amplicon Based Approach v/s Hybridization Based Approach)
    • 5.2.3. By Design (Predesigned Gene Panel v/s Customized Gene Panel)
    • 5.2.4. By Application (Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics, Others)
    • 5.2.5. By End User (Academic & Research Institutes, Hospital & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies)
    • 5.2.6. By Region
    • 5.2.7. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Component
    • 5.3.2. By Technique
    • 5.3.3. By Design
    • 5.3.4. By Application
    • 5.3.5. By End User
    • 5.3.6. By Region

6. North America Gene Panel Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component
    • 6.2.2. By Technique
    • 6.2.3. By Design
    • 6.2.4. By Application
    • 6.2.5. By End User
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Gene Panel Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Component
        • 6.3.1.2.2. By Technique
        • 6.3.1.2.3. By Design
        • 6.3.1.2.4. By Application
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Gene Panel Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Component
        • 6.3.2.2.2. By Technique
        • 6.3.2.2.3. By Design
        • 6.3.2.2.4. By Application
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Gene Panel Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Component
        • 6.3.3.2.2. By Technique
        • 6.3.3.2.3. By Design
        • 6.3.3.2.4. By Application
        • 6.3.3.2.5. By End User

7. Europe Gene Panel Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Technique
    • 7.2.3. By Design
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Gene Panel Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Technique
        • 7.3.1.2.3. By Design
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. Germany Gene Panel Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Technique
        • 7.3.2.2.3. By Design
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. United Kingdom Gene Panel Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Technique
        • 7.3.3.2.3. By Design
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User
    • 7.3.4. Italy Gene Panel Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Component
        • 7.3.4.2.2. By Technique
        • 7.3.4.2.3. By Design
        • 7.3.4.2.4. By Application
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Gene Panel Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Component
        • 7.3.5.2.2. By Technique
        • 7.3.5.2.3. By Design
        • 7.3.5.2.4. By Application
        • 7.3.5.2.5. By End User

8. Asia-Pacific Gene Panel Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Technique
    • 8.2.3. By Design
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Gene Panel Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By Design
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. India Gene Panel Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By Design
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Gene Panel Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By Design
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. South Korea Gene Panel Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Technique
        • 8.3.4.2.3. By Design
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Gene Panel Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Technique
        • 8.3.5.2.3. By Design
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. South America Gene Panel Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Technique
    • 9.2.3. By Design
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Gene Panel Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By Design
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. Argentina Gene Panel Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Technique
        • 9.3.2.2.3. By Design
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. Colombia Gene Panel Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By Design
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User

10. Middle East and Africa Gene Panel Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Technique
    • 10.2.3. By Design
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Gene Panel Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Technique
        • 10.3.1.2.3. By Design
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Saudi Arabia Gene Panel Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Technique
        • 10.3.2.2.3. By Design
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. UAE Gene Panel Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Technique
        • 10.3.3.2.3. By Design
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Product Offerings
  • 13.3. Recent Developments
  • 13.4. Financials (As Reported)
  • 13.5. Key Personnel
  • 13.6. SWOT Analysis
    • 13.6.1. Illumina, Inc.
    • 13.6.2. Agilent Technologies, Inc.
    • 13.6.3. Thermo Fischer Scientific, Inc.
    • 13.6.4. QIAGEN NV
    • 13.6.5. Eurofins Scientific SE
    • 13.6.6. Foundation Medicine Inc.
    • 13.6.7. Guardant Health, Inc.
    • 13.6.8. Myriad Genetic Laboratories Inc.
    • 13.6.9. Bio-Rad Laboratories, Inc.
    • 13.6.10. F. Hoffmann-La Roche AG

14. Strategic Recommendations